300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Medical
Infrastructure
Recruiting
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Web3
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Financial Services
Manufacturing
Digital Media
FinTech
Finance
Franchise
Mobile Advertising
Non Profit
Social Media
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Canada
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Ambria Capital, VC Fund

Ambria Capital

VC Fund

San Juan, Puerto Rico

Ambria Capital is an investment firm that focuses on investing in companies in the agriculture, consumer, healthcare, and technology industries. The company was founded in 2019 and is based in San Juan, Puerto Rico.

Total investments:
10
Last investment:
Lead investor:
20%

Last updated:

Industries Ambria Capital invests in

Health CareMedicalCannabisComplianceMedical Device

Stages Ambria Capital invests in

SeedSeries CSeries APost-IPO EquityConvertible Note

Countries Ambria Capital invests in

United StatesCanada

Contacts

NameEmailPhoneSocials
Michael Sobeck Michael Sobeck

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Investment Focus

Industry

  • Health Care 5 (50%)
  • Medical 2 (20%)
  • Cannabis 2 (20%)
  • Compliance 2 (20%)
  • Medical Device 2 (20%)
See all 20 industries →

Stage

  • Seed 5 (50%)
  • Series C 2 (20%)
  • Series A 1 (10%)
  • Post-IPO Equity 1 (10%)
  • Convertible Note 1 (10%)

Country

  • United States 8 (80%)
  • Canada 1 (10%)

Team

NameTitleInvestmentsLinksEmail
Michael Sobeck
Michael Sobeck Founder and Managing Partner
Founder and Managing Partner Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
HealingMaps HealingMaps
Healing Maps provides education and information about psychedelic-assisted therapies related to Ketamine and beyond. It features in-depth articles related to medical psychedelics, as well as a directory to find the nearest clinics. Founded in 2020, Healing Maps is based in Miami, Florida, United States. $1M / Seed / Sep 15, 2022
Tyson 2.0 Tyson 2.0
Tyson 2.0 is a cannabis company producing cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide. The company wasformed by the legendary boxer, entrepreneur, and icon, Mike Tyson. $9M / Series A / Jun 30, 2022
Maya Health Maya Health
Maya Health's mission is to improve psychedelic practitioners with the technology and data they need to scale safely and effectively, serve more people, and advance psychedelic healthcare. The company was founded in 2019 by David Champion and Akoni Anthony and is based in Denver, Colorado. $3.5M / Seed / Dec 17, 2021
Semasio Semasio
The Fyllo Compliance Cloud is a suite of software and services that enable organizations to navigate today’s ever-changing regulatory landscape, streamline compliance, and scale with speed. Mainstream brands also use the Fyllo Data Marketplace to target previously inaccessible cannabis and CBD consumers.The company was founded in 2019 and isheadquartered in Chicago, Illinois. $40M / Series C / Nov 08, 2021
Semasio (formerly Fyllo) Semasio (formerly Fyllo)
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. $40M / Series C / Nov 08, 2021
MycroDose Therapeutics MycroDose Therapeutics
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system,Ketamine oral mucosa delivery system. Seed / Sep 21, 2021
NanoPsy NanoPsy
NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficaciousAPI. $403.3K / Seed / Jun 29, 2021
WeSana Health WeSana Health
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States. $12.8M / Post-IPO Equity / Mar 31, 2021
WeSana Health WeSana Health
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States. $4M / Convertible Note / Jan 21, 2021
Wonder Sciences Wonder Sciences
Wonder sciences provides mental health and wellness ecosystem that pioneers innovative approaches to treatment and research. Seed / May 01, 2020

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Medical
Infrastructure
Recruiting
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Web3
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Financial Services
Manufacturing
Digital Media
FinTech
Finance
Franchise
Mobile Advertising
Non Profit
Social Media
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Canada
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Ambria Capital invest in?

Ambria Capital invests primarily in Health Care, Medical and Cannabis startups, most often at Seed and Series C stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Ambria Capital?

Public channels for Ambria Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Ambria Capital?

The team at Ambria Capital includes Michael Sobeck (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Ambria Capital Ambria Capital Find emails